CBT Advisors is a consultancy founded in 2003 working with private biotechnology, life sciences and medical device companies on storytelling and strategy. We are based in Cambridge, MA. Much of the firm’s work focuses on drafting business sections for NASDAQ IPOs. As of October, 2020, fifty-nine clients have gone public, raising $5.9 billion. Recent IPO clients have included Zentalis, Repare, Black Diamond, Pliant Therapeutics, iTeos, Legend Biotech and Allovir. Earlier clients included CRISPR Therapeutics, Karuna Therapeutics, Alector, Translate Bio, ArgenX, Personalis, Inspire Medical, Vapotherm and others.